Literature DB >> 17575207

Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.

Alan Jackson1, James P B O'Connor, Geoff J M Parker, Gordon C Jayson.   

Abstract

This article reviews the application of dynamic contrast-enhanced magnetic resonance imaging in both clinical studies and early-phase trials of angiogenesis inhibitors. Emphasis is placed on how variation in image acquisition and analysis affects the meaning and use of derived variables. We then review the potential for future developments, with particular reference to the application of dynamic contrast-enhanced magnetic resonance imaging to evaluate the heterogeneity of tumor tissues.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17575207     DOI： 10.1158/1078-0432.CCR-07-0238

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  105 in total

Review 1.  Evaluation of treatment response in patients with metastatic renal cell carcinoma: role of state-of-the-art cross-sectional imaging.

Authors:  Venkata S Katabathina; Nathalie Lassau; Ivan Pedrosa; Chaan S Ng; Srinivasa R Prasad
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

Review 2.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies.

Authors:  James P B O'Connor; Alan Jackson; Geoff J M Parker; Caleb Roberts; Gordon C Jayson
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675

Review 3.  Dynamic contrast-enhanced imaging techniques: CT and MRI.

Authors:  J P B O'Connor; P S Tofts; K A Miles; L M Parkes; G Thompson; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 4.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

5.  Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis.

Authors:  A Karahaliou; K Vassiou; N S Arikidis; S Skiadopoulos; T Kanavou; L Costaridou
Journal:  Br J Radiol       Date:  2010-04       Impact factor: 3.039

6.  An expectation-maximisation approach for simultaneous pixel classification and tracer kinetic modelling in dynamic contrast enhanced-magnetic resonance imaging.

Authors:  Mario Sansone; Roberta Fusco; Antonella Petrillo; Mario Petrillo; Marcello Bracale
Journal:  Med Biol Eng Comput       Date:  2010-11-03       Impact factor: 2.602

7.  Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research.

Authors:  Kejia Cai; Adam Shore; Anup Singh; Mohammad Haris; Teruyuki Hiraki; Prianka Waghray; Damodar Reddy; Joel H Greenberg; Ravinder Reddy
Journal:  NMR Biomed       Date:  2012-02-02       Impact factor: 4.044

8.  Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.

Authors:  Jacobus Fa Jansen; Yonggang Lu; Gaorav Gupta; Nancy Y Lee; Hilda E Stambuk; Yousef Mazaheri; Joseph O Deasy; Amita Shukla-Dave
Journal:  World J Radiol       Date:  2016-01-28

9.  Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.

Authors:  Kejia Cai; He N Xu; Anup Singh; Lily Moon; Mohammad Haris; Ravinder Reddy; Lin Z Li
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

10.  Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

Authors:  Allison F O'Neill; Lei Qin; Patrick Y Wen; John F de Groot; Annick D Van den Abbeele; Jeffrey T Yap
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.